Director Johnson Karen Marie bought Oncology Institute, Inc. ($TOI) shares once on the open market in the last year, for a total of nearly $38,000. Her most recent purchase occurred on March 26, 2025. Among nearly 5,000 insiders tracking open market buys, her activity ranks 3,272nd by amount, below the average of about $1.5 million across 3.3 transactions per insider. She reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Johnson Karen Marie | Director | A | Common Stock | 47840 | $0.00 | 251,249.0000 | 99,303,511 | 23.52% | 0.05% |
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Johnson Karen Marie | Director | A | Common Stock | 37037 | $0.00 | 288,286.0000 | 99,303,511 | 14.74% | 0.04% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Johnson Karen Marie | Director | P | Common Stock | 36224 | $1.04 | 203,409.0000 | 77,470,886 | 21.67% | 0.05% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Johnson Karen Marie | Director | P | Common Warrant | 18112 | $0.13 | 18,112.0000 | 77,470,886 | 9999.99% | 0.02% |
| Nov. 22, 2024 | Oncology Institute, Inc. | $TOI | Johnson Karen Marie | Director | A | Common stock | 52000 | $0.00 | 167,185.0000 | 77,292,849 | 45.14% | 0.07% |
| Dec. 26, 2023 | Oncology Institute, Inc. | $TOI | Johnson Karen Marie | Director | A | Common stock | 52000 | $0.00 | 115,185.0000 | 73,265,621 | 82.30% | 0.07% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Johnson Karen Marie | Director | A | Common stock | 19685 | $0.00 | 63,185.0000 | 73,265,621 | 45.25% | 0.03% |